Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
- PMID: 11136970
- DOI: 10.1016/s0092-8674(00)00188-4
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
Abstract
Many cofactors bind the hormone-activated estrogen receptor (ER), yet the specific regulators of endogenous ER-mediated gene transcription are unknown. Using chromatin immunoprecipitation (ChIP), we find that ER and a number of coactivators rapidly associate with estrogen responsive promoters following estrogen treatment in a cyclic fashion that is not predicted by current models of hormone activation. Cycles of ER complex assembly are followed by transcription. In contrast, the anti-estrogen tamoxifen (TAM) recruits corepressors but not coactivators. Using a genetic approach, we show that recruitment of the p160 class of coactivators is sufficient for gene activation and for the growth stimulatory actions of estrogen in breast cancer supporting a model in which ER cofactors play unique roles in estrogen signaling.
Similar articles
-
Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.Mol Endocrinol. 2003 Jul;17(7):1296-314. doi: 10.1210/me.2001-0316. Epub 2003 Apr 24. Mol Endocrinol. 2003. PMID: 12714702
-
Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.J Clin Endocrinol Metab. 2004 Jan;89(1):375-83. doi: 10.1210/jc.2003-031048. J Clin Endocrinol Metab. 2004. PMID: 14715875
-
Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.J Mol Endocrinol. 2004 Oct;33(2):387-410. doi: 10.1677/jme.1.01541. J Mol Endocrinol. 2004. PMID: 15525597
-
p33ING1b and estrogen receptor (ER) alpha.Breast Cancer. 2004;11(1):33-7. doi: 10.1007/BF02967999. Breast Cancer. 2004. PMID: 14718790 Review.
-
Epigenetic regulation of estrogen signaling in breast cancer.Epigenetics. 2013 Mar;8(3):237-45. doi: 10.4161/epi.23790. Epub 2013 Jan 30. Epigenetics. 2013. PMID: 23364277 Free PMC article. Review.
Cited by
-
Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α.Nat Chem Biol. 2013 May;9(5):326-32. doi: 10.1038/nchembio.1214. Epub 2013 Mar 24. Nat Chem Biol. 2013. PMID: 23524984 Free PMC article.
-
Aldose Reductase Acts as a Selective Derepressor of PPARγ and the Retinoic Acid Receptor.Cell Rep. 2016 Apr 5;15(1):181-196. doi: 10.1016/j.celrep.2016.02.086. Epub 2016 Mar 24. Cell Rep. 2016. PMID: 27052179 Free PMC article.
-
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.PPAR Res. 2012;2012:269751. doi: 10.1155/2012/269751. Epub 2012 Feb 29. PPAR Res. 2012. PMID: 22619672 Free PMC article.
-
Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.PLoS One. 2012;7(1):e30174. doi: 10.1371/journal.pone.0030174. Epub 2012 Jan 19. PLoS One. 2012. PMID: 22276155 Free PMC article.
-
Liver X receptor alpha mediated genistein induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1) in Hep G2 cells.Toxicol Appl Pharmacol. 2013 Apr 15;268(2):106-12. doi: 10.1016/j.taap.2013.01.006. Epub 2013 Jan 23. Toxicol Appl Pharmacol. 2013. PMID: 23352501 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous